CD99/MIC-2 surface protein expression in breast carcinomas

Histopathology
Fernanda MilaneziFernando C Schmitt

Abstract

To evaluate the expression of CD99/MIC-2 surface protein in invasive breast carcinomas and demonstrate whether or not there is a relationship with tumour phenotype. Thirty-five invasive breast carcinomas, including five metaplastic carcinomas, were stained with CD99 primary antibodies using standard protocols based on streptavidin-biotin-peroxidase method. Four out of five metaplastic carcinomas expressed CD99/MIC-2 protein, three of them were matrix-producing carcinomas. From the other 30 cases, only an invasive apocrine carcinoma was positive. There was no statistical correlation between CD99 expression and the parameters analysed (histological typing and grading, proliferative index and nodal status). CD99/MIC-2 is expressed in breast carcinomas, especially in the matrix-producing variant of metaplastic carcinomas, which impairs its use as a marker to differentiate metaplastic carcinomas from primary and metastatic sarcomas of the breast. It seems to have no prognostic implications. However, phenotype similarities with other chondromyxoid tumours that also express the protein, like mesenchymal chondrosarcomas, suggest a relationship between MIC-2 reactivity and morphological differentiation.

References

Jul 1, 1989·Human Pathology·E S Wargotz, H J Norris
Jan 1, 1995·Virchows Archiv : an International Journal of Pathology·F C SchmittM Lacerda
Dec 1, 1996·Human Pathology·S R GranterA E Rosenberg
May 1, 1997·The American Journal of Surgical Pathology·M RishiF A Tavassoli
Feb 4, 1999·Annals of Diagnostic Pathology·C Fisher
Jul 8, 1999·Virchows Archiv : an International Journal of Pathology·R Lázaro-SantanderJ M Vera-Roman
Oct 19, 2000·Virchows Archiv : an International Journal of Pathology·G PelosiG Viale

❮ Previous
Next ❯

Citations

Jul 16, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Kimihide KusafukaToru Kameya
Jan 31, 2004·American Journal of Clinical Pathology·Simon BergmanJacqueline K Trupiano
Mar 26, 2011·Pathology Research International·Tibor TotLeif Bergkvist
Feb 26, 2016·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Atsuko HadanoTetsuya Mine
Apr 6, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Giuseppe PelosiGiuseppe Viale
Mar 27, 2009·Journal of Cutaneous Pathology·A PattonR King
Jun 20, 2007·Journal of Cutaneous Pathology·Mark S KingKim M Hiatt
Oct 10, 2006·Journal of Cutaneous Pathology·Anne E WilkersonKim M Hiatt
Mar 7, 2012·International Journal of Cancer. Journal International Du Cancer·Karolina EdlundPatrick Micke
Jan 7, 2018·Journal of Cell Communication and Signaling·Michela PaselloKatia Scotlandi
Mar 14, 2018·Genes·Maria Cristina ManaraKatia Scotlandi
Jul 19, 2012·Oncology Letters·Suebwong ChuthapisithTamnit Angsusinha
Oct 5, 2018·Human Antibodies·Krishna Priya ThangaretnamThangarajan Rajkumar
Oct 22, 2014·Clinics and Practice·Sawsen MeddebMohamed Tahar Yacoubi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.